Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bei Cao

Showing results (231-240 of 337) with videos related to

Pageof 34
Sort By:
Molecular Neurobiology|March 26, 2022
lncRNA BDNF-AS Attenuates Propofol-Induced Apoptosis in HT22 Cells by Modulating the BDNF/TrkB PathwayYu-Hai Xu, Yuan Luo, Jiang-Bei Cao, et al.
Neurobiology of Disease|October 24, 2022
Genetic analysis of and clinical characteristics associated with ANXA11 variants in a Chinese cohort with amyotrophic lateral sclerosisQirui Jiang, Junyu Lin, Qianqian Wei, et al.
Neurobiology of Aging|June 9, 2020
Mutation screening and burden analysis of VPS13C in Chinese patients with early-onset Parkinson's diseaseXiaojing Gu, Chunyu Li, Yongping Chen, et al.
Membranes|March 24, 2022
Dysfunction of EAAT3 Aggravates LPS-Induced Post-Operative Cognitive DysfunctionXiao-Yan Wang, Wen-Gang Liu, Ai-Sheng Hou, et al.
Brain, Behavior, and Immunity|July 28, 2019
IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's diseaseZhan Liu, Ao-Wang Qiu, Yan Huang, et al.
Molecular Neurobiology|February 7, 2024
Discovery and Exploration of Lipid-Modifying Drug Targets for ALS by Mendelian RandomizationZheng Jiang, Xiao-Jing Gu, Wei-Ming Su, et al.
BMC Medicine|December 23, 2025
Loss of Y chromosome and its implications in male amyotrophic lateral sclerosis: insights from the UK BiobankWei-Ming Su, Qing-Qing Duan, Sheng-Yi He, et al.
Expert Opinion on Investigational Drugs|August 21, 2024
The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjectsTingting Ma, Zuyi Weng, Bei Cao, et al.
Frontiers in Aging Neuroscience|December 15, 2022
Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort studyLingyu Zhang, Ruicen Li, Yanbing Hou, et al.
Frontiers in Pharmacology|December 29, 2022
First-in-human study to assess the safety, tolerability, pharmacokinetics and immunogenicity of DS002, an anti-nerve growth factor monoclonal antibodyTingting Ma, Bei Cao, Lei Huang, et al.
Pageof 34

Showing results (231-240 of 337) with videos related to

Sort By:
Pageof 34
Molecular Neurobiology|March 26, 2022
lncRNA BDNF-AS Attenuates Propofol-Induced Apoptosis in HT22 Cells by Modulating the BDNF/TrkB PathwayYu-Hai Xu, Yuan Luo, Jiang-Bei Cao, et al.
Neurobiology of Disease|October 24, 2022
Genetic analysis of and clinical characteristics associated with ANXA11 variants in a Chinese cohort with amyotrophic lateral sclerosisQirui Jiang, Junyu Lin, Qianqian Wei, et al.
Neurobiology of Aging|June 9, 2020
Mutation screening and burden analysis of VPS13C in Chinese patients with early-onset Parkinson's diseaseXiaojing Gu, Chunyu Li, Yongping Chen, et al.
Membranes|March 24, 2022
Dysfunction of EAAT3 Aggravates LPS-Induced Post-Operative Cognitive DysfunctionXiao-Yan Wang, Wen-Gang Liu, Ai-Sheng Hou, et al.
Brain, Behavior, and Immunity|July 28, 2019
IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's diseaseZhan Liu, Ao-Wang Qiu, Yan Huang, et al.
Molecular Neurobiology|February 7, 2024
Discovery and Exploration of Lipid-Modifying Drug Targets for ALS by Mendelian RandomizationZheng Jiang, Xiao-Jing Gu, Wei-Ming Su, et al.
BMC Medicine|December 23, 2025
Loss of Y chromosome and its implications in male amyotrophic lateral sclerosis: insights from the UK BiobankWei-Ming Su, Qing-Qing Duan, Sheng-Yi He, et al.
Expert Opinion on Investigational Drugs|August 21, 2024
The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjectsTingting Ma, Zuyi Weng, Bei Cao, et al.
Frontiers in Aging Neuroscience|December 15, 2022
Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort studyLingyu Zhang, Ruicen Li, Yanbing Hou, et al.
Frontiers in Pharmacology|December 29, 2022
First-in-human study to assess the safety, tolerability, pharmacokinetics and immunogenicity of DS002, an anti-nerve growth factor monoclonal antibodyTingting Ma, Bei Cao, Lei Huang, et al.
Pageof 34